194 related articles for article (PubMed ID: 18221064)
41. Potassium channel subtypes as molecular targets for overactive bladder and other urological disorders.
Gopalakrishnan M; Shieh CC
Expert Opin Ther Targets; 2004 Oct; 8(5):437-58. PubMed ID: 15469394
[TBL] [Abstract][Full Text] [Related]
42. Voltage-gated and ATP-sensitive K+ channels are associated with cell proliferation and tumorigenesis of human glioma.
Ru Q; Tian X; Wu YX; Wu RH; Pi MS; Li CY
Oncol Rep; 2014 Feb; 31(2):842-8. PubMed ID: 24284968
[TBL] [Abstract][Full Text] [Related]
43. Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents.
Tian M; Dong MQ; Chiu SW; Lau CP; Li GR
Br J Pharmacol; 2006 Feb; 147(3):289-97. PubMed ID: 16341233
[TBL] [Abstract][Full Text] [Related]
44. KATP channel openers: structure-activity relationships and therapeutic potential.
Mannhold R
Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
[TBL] [Abstract][Full Text] [Related]
45. Na+/K+-ATPase and cancer.
Mijatovic T; Dufrasne F; Kiss R
Pharm Pat Anal; 2012 Mar; 1(1):91-106. PubMed ID: 24236716
[TBL] [Abstract][Full Text] [Related]
46. Effects of arsenic trioxide on voltage-dependent potassium channels and on cell proliferation of human multiple myeloma cells.
Zhou J; Wang W; Wei QF; Feng TM; Tan LJ; Yang BF
Chin Med J (Engl); 2007 Jul; 120(14):1266-9. PubMed ID: 17697580
[No Abstract] [Full Text] [Related]
47. Calcitonin gene-related peptide stimulates potassium efflux through adenosine triphosphate-sensitive potassium channels and produces membrane hyperpolarization in osteoblastic UMR106 cells.
Kawase T; Burns DM
Endocrinology; 1998 Aug; 139(8):3492-502. PubMed ID: 9681500
[TBL] [Abstract][Full Text] [Related]
48. NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels.
Pillozzi S; Gasparoli L; Stefanini M; Ristori M; D'Amico M; Alessio E; Scaletti F; Becchetti A; Arcangeli A; Messori L
Dalton Trans; 2014 Aug; 43(32):12150-5. PubMed ID: 24975719
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of potassium currents as a pharmacologic target for investigation in chronic lymphocytic leukemia.
Biderman B; Marakhonov A; Skoblov M; Birerdinc A; Nohelty E; Page S; Khomenkov V; Chandhoke V; Sudarikov A; Nikitin E; Baranova A
Drug News Perspect; 2010 Dec; 23(10):625-31. PubMed ID: 21180648
[TBL] [Abstract][Full Text] [Related]
50. Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.
Valverde P; Kawai T; Taubman MA
J Dent Res; 2005 Jun; 84(6):488-99. PubMed ID: 15914584
[TBL] [Abstract][Full Text] [Related]
51. Studying cardiac arrhythmias in the mouse--a reasonable model for probing mechanisms?
Nerbonne JM
Trends Cardiovasc Med; 2004 Apr; 14(3):83-93. PubMed ID: 15121155
[TBL] [Abstract][Full Text] [Related]
52. Potassium channel currents in rat mesenchymal stem cells and their possible roles in cell proliferation.
Wang SP; Wang JA; Luo RH; Cui WY; Wang H
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1077-84. PubMed ID: 18505444
[TBL] [Abstract][Full Text] [Related]
53. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
54. Mitochondrial potassium channels.
Szewczyk A; Jarmuszkiewicz W; Kunz WS
IUBMB Life; 2009 Feb; 61(2):134-43. PubMed ID: 19165895
[TBL] [Abstract][Full Text] [Related]
55. Roles of K+ channels in regulating tumour cell proliferation and apoptosis.
Wang Z
Pflugers Arch; 2004 Jun; 448(3):274-86. PubMed ID: 15048575
[TBL] [Abstract][Full Text] [Related]
56. Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease.
Pelaia G; Gallelli L; Vatrella A; Grembiale RD; Maselli R; De Sarro GB; Marsico SA
Life Sci; 2002 Jan; 70(9):977-90. PubMed ID: 11862989
[TBL] [Abstract][Full Text] [Related]
57. 4-aminopyridine decreases progesterone production by porcine granulosa cells.
Li Y; Ganta S; von Stein FB; Mason DE; Mitchell BM; Freeman LC
Reprod Biol Endocrinol; 2003 Apr; 1():31. PubMed ID: 12740033
[TBL] [Abstract][Full Text] [Related]
58. Properties of Xenopus Kv1.10 channels expressed in HEK293 cells.
Fry M; Maue RA; Moody-Corbett F
J Neurobiol; 2004 Aug; 60(2):227-35. PubMed ID: 15266653
[TBL] [Abstract][Full Text] [Related]
59. Levosimendan interacts with potassium channel blockers in human saphenous veins.
Höhn J; Pataricza J; Petri A; Tóth GK; Balogh A; Varró A; Papp JG
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):271-3. PubMed ID: 15228498
[TBL] [Abstract][Full Text] [Related]
60. Potassium channels in atrial fibrillation: targets for atrial and pathology-specific therapy?
Ravens U
Heart Rhythm; 2008 May; 5(5):758-9. PubMed ID: 18452882
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
